Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia

Journal of Experimental Medicine

Volumn 211, Issue 1, 2014, Pages 165-179

  Cotechini, Tiziana ^a   Komisarenko, Maria ^a   Sperou, Arissa ^a   Macdonald Goodfellow, Shannyn ^a   Adams, Michael A ^a   Graham, Charles H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETAL GROWTH RESTRICTION; FETUS DISEASE; FETUS WEIGHT; GESTATIONAL AGE; GRANULOCYTE; HEMODYNAMICS; INFANT; LEUKOCYTE COUNT; LYMPHOCYTE; MATERNAL DISEASE; MATERNAL INFLAMMATION; MEAN ARTERIAL PRESSURE; MONOCYTE; NITROSATIVE STRESS; NONHUMAN; ORGAN PERFUSION; PLACENTAL NITROSATIVE STRESS; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEINURIA; RAT; SPIRAL ARTERY REMODELING; TROPHOBLAST; UTEROPLACENTAL HEMODYNAMIC; UTEROPLACENTAL PERFUSION;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD CELL COUNT; BLOOD PRESSURE; CREATININE; ENDOMETRIUM; FEMALE; FETAL GROWTH RETARDATION; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY; LIPOPOLYSACCHARIDES; MYOCYTES, SMOOTH MUSCLE; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; RATS; TELEMETRY; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY, DOPPLER; UTERINE ARTERY;

EID: 84892511276     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130295     Document Type: Article

References (93)

1. Acharya, G., T. Wilsgaard, G.K. Berntsen, J.M. Maltau, and T. Kiserud. 2005. Reference ranges for serial measurements of blood velocity and pulsatility index at the intra-abdominal portion, and fetal and placental ends of the umbilical artery. Ultrasound Obstet. Gynecol. 26:162-169. http://dx .doi.org/10.1002/uog.1902.
2. Bauer, S., J. Pollheimer, J. Hartmann, P. Husslein, J.D. Aplin, and M. Knöfler. 2004. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J. Clin. Endocrinol. Metab. 89:812-822. http://dx .doi.org/10.1210/jc.2003-031351.
3. Berks, D., E.A. Steegers, M. Molas, and W. Visser. 2009. Resolution of hypertension and proteinuria after preeclampsia. Obstet. Gynecol. 114: 1307-1314.
4. Berthelsen, B.G., H. Fjeldsøe-Nielsen, C.T. Nielsen, and E. Hellmuth. 2010. Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding. Rheumatology (Oxford). 49:2225-2227. http://dx.doi.org/10.1093/rheumatology/keq185.
5. Boersma, B., and J.M. Wit. 1997. Catch-up growth. Endocr. Rev. 18:646-661. http://dx.doi.org/10.1210/er.18.5.646.
6. Borzychowski, A.M., I.L. Sargent, and C.W. Redman. 2006. Inflammation and pre-eclampsia. Semin. Fetal Neonatal Med. 11:309-316. http://dx.doi .org/10.1016/j.siny.2006.04.001.
7. Boulanger, C., and T.F. Lüscher. 1990. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85:587-590. http://dx.doi.org/10.1172/JCI114477.
8. Bourque, S.L., S.T. Davidge, and M.A. Adams. 2011. The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300:R1288-R1295. http://dx.doi .org/10.1152/ajpregu.00397.2010.
9. Bourque, S.L., H.A. Whittingham, S.E. Brien, S.T. Davidge, and M.A. Adams. 2012. Role of endothelin-1 in the hyper-responsiveness to nitrovasodilators following acute NOS inhibition. Br. J. Pharmacol. 165:1992-1999. http://dx.doi.org/10.1111/j.1476-5381.2011.01696.x.
10. Boyd, J.D., and W.J. Hamilton. 1970. The Human Placenta. W. Heffer and Sons Ltd., Cambridge, England. 137 pp.
11. Bridgman, J. 1948. A morphological study of the development of the placenta of the rat; an histological and cytological study of the development of the chorioallantoic palcenta of the white rat. J. Morphol. 83:195-223. http://dx.doi.org/10.1002/jmor.1050830204.
12. Burton, G.J., and E. Jauniaux. 2011. Oxidative stress. Best Pract. Res. Clin. Obstet. Gynaecol. 25:287-299. http://dx.doi.org/10.1016/j.bpobgyn .2010.10.016.
13. Burton, G.J., A.W. Woods, E. Jauniaux, and J.C. Kingdom. 2009. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 30:473-482. http://dx.doi.org/10.1016/j.placenta.2009.02.009.
14. Byun, Y.J., H.S. Kim, J.I. Yang, J.H. Kim, H.Y. Kim, and S.J. Chang. 2009. Umbilical artery Doppler study as a predictive marker of perinatal outcome in preterm small for gestational age infants. Yonsei Med. J. 50:39-44. http://dx.doi.org/10.3349/ymj.2009.50.1.39.
15. Carter, J.D., A. Ladhani, L.R. Ricca, J. Valeriano, and F.B. Vasey. 2009. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J. Rheumatol. 36:635-641. http://dx.doi.org/10.3899/jrheum.080545.
16. Chahoud, I., and F.J. Paumgartten. 2009. Influence of litter size on the postnatal growth of rat pups: is there a rationale for litter-size standardization in toxicity studies? Environ. Res. 109:1021-1027. http://dx.doi.org/10 .1016/j.envres.2009.07.015.
17. Chaparro, A., A. Sanz, A. Quintero, C. Inostroza, V. Ramirez, F. Carrion, F. Figueroa, R. Serra, and S.E. Illanes. 2013. Increased inflammatory biomarkers in early pregnancy is associated with the development of preeclampsia in patients with periodontitis: a case control study. J. Periodontal Res. 48:302-307. http://dx.doi.org/10.1111/jre.12008.
18. Collins, S.L., J.S. Birks, G.N. Stevenson, A.T. Papageorghiou, J.A. Noble, and L. Impey. 2012. Measurement of spiral artery jets: general principles and differences observed in small-for-gestational-age pregnancies. Ultrasound Obstet. Gynecol. 40:171-178. http://dx.doi.org/10.1002/uog.10149.
19. Conde-Agudelo, A., J. Villar, and M. Lindheimer. 2008. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am. J. Obstet. Gynecol. 198:7-22. http://dx.doi.org/10.1016/j.ajog.2007. 07.040.
20. Conrad, K.P., T.M. Miles, and D.F. Benyo. 1998. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am. J. Reprod. Immunol. 40:102-111. http://dx.doi.org/10.1111/j.1600-0897.1998.tb00398.x.
21. Cotechini, T., M. Othman, and C.H. Graham. 2012. Nitroglycerin prevents coagulopathies and foetal death associated with abnormal maternal inflammation in rats. Thromb. Haemost. 107:864-874. http://dx.doi.org/10.1160/TH11-10-0730.
22. de Pace, V., G. Chiossi, and F. Facchinetti. 2007. Clinical use of nitric oxide donors and l-arginine in obstetrics. J. Matern. Fetal Neonatal Med. 20:569-579. http://dx.doi.org/10.1080/14767050701419458.
23. Dechend, R., P. Gratze, G. Wallukat, E. Shagdarsuren, R. Plehm, J.H. Bräsen, A. Fiebeler, W. Schneider, S. Caluwaerts, L. Vercruysse, et al. 2005. Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension. 45:742-746. http://dx.doi.org/10.1161/01 .HYP.0000154785.50570.63.
24. Faas, M.M., G.A. Schuiling, J.F. Baller, C.A. Visscher, and W.W. Bakker. 1994. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am. J. Obstet. Gynecol. 171:158-164. http://dx.doi.org/10.1016/0002-9378(94)90463-4.
25. Faas, M.M., G.A. Schuiling, J.F. Baller, and W.W. Bakker. 1995. Glomerular inflammation in pregnant rats after infusion of low dose endotoxin. An immunohistological study in experimental pre-eclampsia. Am. J. Pathol. 147:1510-1518.
26. Faas, M.M., M. Broekema, H. Moes, G. van der Schaaf, M.J. Heineman, and P. de Vos. 2004. Altered monocyte function in experimental preeclampsia in the rat. Am. J. Obstet. Gynecol. 191:1192-1198. http://dx.doi.org/10.1016/j.ajog.2004.03.041.
27. Falcón, B.J., T. Cotechini, S.K. Macdonald-Goodfellow, M. Othman, and C.H. Graham. 2012. Abnormal inflammation leads to maternal coagulopathies associated with placental haemostatic alterations in a rat model of foetal loss. Thromb. Haemost. 107:438-447. http://dx.doi.org/10.1160/TH11-09-0626.
28. Gao, X., H. Zhang, S. Belmadani, J. Wu, X. Xu, H. Elford, B.J. Potter, and C. Zhang. 2008. Role of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 295:H2242-H2249. http://dx.doi.org/10.1152/ajpheart .00587.2008.
29. Gardosi, J., A. Chang, B. Kalyan, D. Sahota, and E.M. Symonds. 1992. Customised antenatal growth charts. Lancet. 339:283-287. http://dx.doi .org/10.1016/0140-6736(92)91342-6.
30. Germain, S.J., G.P. Sacks, S.R. Sooranna, I.L. Sargent, and C.W. Redman. 2007. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J. Immunol. 178: 5949-5956.
31. Hamai, Y., T. Fujii, T. Yamashita, H. Nishina, S. Kozuma, Y. Mikami, and Y. Taketani. 1997. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am. J. Reprod. Immunol. 38:89-93. http://dx.doi.org/10.1111/j.1600-0897.1997.tb00281.x.
32. Hung, T.H., D.S. Charnock-Jones, J.N. Skepper, and G.J. Burton. 2004. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am. J. Pathol. 164:1049-1061. http://dx.doi.org/10.1016/S0002-9440(10)63192-6.
33. Hunt, J.S. 1989. Macrophages in human uteroplacental tissues: a review. Am. J. Reprod. Immunol. 21:119-122. http://dx.doi.org/10.1111/j.1600-0897.1989.tb01015.x.
34. Jain, K., V. Kavi, C.V. Raghuveer, and R. Sinha. 2007. Placental pathology in pregnancy-induced hypertension (PIH) with or without intrauterine growth retardation. Indian J. Pathol. Microbiol. 50:533-537.
35. Kadyrov, M., C. Schmitz, S. Black, P. Kaufmann, and B. Huppertz. 2003. Pre-eclampsia and maternal anaemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. Placenta. 24:540-548. http://dx.doi.org/10.1053/plac.2002.0946.
36. Kam, E.P., L. Gardner, Y.W. Loke, and A. King. 1999. The role of trophoblast in the physiological change in decidual spiral arteries. Hum. Reprod. 14:2131-2138. http://dx.doi.org/10.1093/humrep/14.8.2131.
37. Kaufmann, P., S. Black, and B. Huppertz. 2003. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod. 69:1-7. http://dx.doi.org/10.1095/biolreprod.102.014977.
38. Knight, M., C.W.G. Redman, E.A. Linton, and I.L. Sargent. 1998. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br. J. Obstet. Gynaecol. 105:632-640. http://dx.doi.org/10.1111/j.1471-0528.1998.tb10178.x.
39. Knöfler, M., M. Stenzel, and P. Husslein. 1998. Shedding of tumour necrosis factor receptors from purified villous term trophoblasts and cytotrophoblastic BeWo cells. Hum. Reprod. 13:2308-2316. http://dx.doi.org/10.1093/humrep/13.8.2308.
40. Koga, K., Y. Osuga, T. Tajima, Y. Hirota, T. Igarashi, T. Fujii, T. Yano, and Y. Taketani. 2010. Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole. Fertil. Steril. 94:305-308. http://dx.doi.org/10.1016/j.fertnstert.2009.02.015.
41. Kourembanas, S., L.P. McQuillan, G.K. Leung, and D.V. Faller. 1993. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92:99-104. http://dx.doi.org/10.1172/JCI116604.
42. LaMarca, B.B., W.A. Bennett, B.T. Alexander, K. Cockrell, and J.P. Granger. 2005. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension. 46:1022-1025. http://dx.doi.org/10.1161/01.HYP.0000175476.26719.36.
43. LaMarca, B.D., M.J. Ryan, J.S. Gilbert, S.R. Murphy, and J.P. Granger. 2007. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr. Hypertens. Rep. 9:480-485. http://dx.doi.org/10 .1007/s11906-007-0088-1.
44. Lau, S.Y., C.J. Barrett, S.J. Guild, and L.W. Chamley. 2013. Necrotic trophoblast debris increases blood pressure during pregnancy. J. Reprod. Immunol. 97:175-182. http://dx.doi.org/10.1016/j.jri.2012.12.005.
45. Li, Z., Y. Zhang, J. Ying Ma, A.M. Kapoun, Q. Shao, I. Kerr, A. Lam, G. O'Young, F. Sannajust, P. Stathis, et al. 2007. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension. 50:686-692. http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.092098.
46. Lin, F., P. Zeng, Z. Xu, D. Ye, X. Yu, N. Wang, J. Tang, Y. Zhou, and Y. Huang. 2012. Treatment of Lipoxin A(4) and its analogue on low-dose endotoxin induced preeclampsia in rat and possible mechanisms. Reprod. Toxicol. 34:677-685. http://dx.doi.org/10.1016/j.reprotox.2012.09.009.
47. Liu, M., and G. Bing. 2011. Lipopolysaccharide animal models for Parkinson's disease. Parkinsons Dis. 2011:327089.
48. Lowe, D.T. 2000. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide. 4:441-458. http://dx.doi.org/10.1006/niox.2000 .0296.
49. Lyall, F., and M. Belfort. 2007. Pre-eclampsia: Etiology and Clinical Practice. Cambridge University Press, Cambridge.
50. Marsden, P.A., and B.M. Brenner. 1992. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am. J. Physiol. 262:C854-C861.
51. McDonald, T.E., M.N. Grinman, C.M. Carthy, and K.R. Walley. 2000. Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am. J. Physiol. Heart Circ. Physiol. 279:H2053-H2061.
52. Mor, G., and I. Cardenas. 2010. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol. 63:425-433. http://dx.doi .org/10.1111/j.1600-0897.2010.00836.x.
53. Mu, J., and S.L. Adamson. 2006. Developmental changes in hemodynamics of uterine artery, utero-and umbilicoplacental, and vitelline circulations in mouse throughout gestation. Am. J. Physiol. Heart Circ. Physiol. 291:H1421-H1428. http://dx.doi.org/10.1152/ajpheart.00031.2006.
54. Naicker, T., S.M. Khedun, J. Moodley, and R. Pijnenborg. 2003. Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet. Gynecol. Scand. 82:722-729. http://dx.doi.org/10.1034/j.1600-0412.2003.00220.x.
55. Nemzek, J.A., K.M. Hugunin, and M.R. Opp. 2008. Modeling sepsis in the laboratory: merging sound science with animal well-being. Comp. Med. 58:120-128.
56. Otun, H.A., G.E. Lash, B.A. Innes, J.N. Bulmer, K. Naruse, T. Hannon, R.F. Searle, and S.C. Robson. 2011. Effect of tumour necrosis factor-α in combination with interferon-γ on first trimester extravillous trophoblast invasion. J. Reprod. Immunol. 88:1-11. http://dx.doi.org/10.1016/j.jri.2010.10.003.
57. Page, E. 1939. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am. J. Obstet. Gynecol. 37:291-293.
58. Peleg, D., C.M. Kennedy, and S.K. Hunter. 1998. Intrauterine growth restriction: identification and management. Am. Fam. Physician. 58:453-460: 466-467.
59. Peraçoli, J.C., M.V. Rudge, and M.T. Peraçoli. 2007. Tumor necrosis factoralpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am. J. Reprod. Immunol. 57:177-185. http://dx .doi.org/10.1111/j.1600-0897.2006.00455.x.
60. Pijnenborg, R., J.M. Bland, W.B. Robertson, and I. Brosens. 1983. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta. 4:397-413. http://dx.doi.org/10.1016/S0143-4004(83)80043-5.
61. Pijnenborg, R., L. Vercruysse, and M. Hanssens. 2006. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta. 27:939-958. http://dx.doi.org/10.1016/j.placenta.2005.12.006.
62. Redman, C.W.G. 1991. Current topic: pre-eclampsia and the placenta. Placenta. 12:301-308. http://dx.doi.org/10.1016/0143-4004(91)90339-H.
63. Redman, C.W.G., and M. Jefferies. 1988. Revised definition of pre-eclampsia. Lancet. 1:809-812. http://dx.doi.org/10.1016/S0140-6736(88)91667-4.
64. Redman, C.W., G.P. Sacks, and I.L. Sargent. 1999. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 180:499-506. http://dx.doi.org/10.1016/S0002-9378(99)70239-5.
65. Reister, F., H.G. Frank, W. Heyl, G. Kosanke, B. Huppertz, W. Schröder, P. Kaufmann, and W. Rath. 1999. The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta. 20:229-233. http://dx.doi.org/10.1053/plac.1998.0373.
66. Reister, F., H.G. Frank, J.C. Kingdom, W. Heyl, P. Kaufmann, W. Rath, and B. Huppertz. 2001. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab. Invest. 81:1143-1152. http://dx.doi.org/10.1038/labinvest.3780326.
67. Renaud, S.J., L.M. Postovit, S.K. Macdonald-Goodfellow, G.T. McDonald, J.D. Caldwell, and C.H. Graham. 2005. Activated macrophages inhibit human cytotrophoblast invasiveness in vitro. Biol. Reprod. 73:237-243. http://dx.doi.org/10.1095/biolreprod.104.038000.
68. Renaud, S.J., S.K. Macdonald-Goodfellow, and C.H. Graham. 2007. Coordinated regulation of human trophoblast invasiveness by macrophages and interleukin 10. Biol. Reprod. 76:448-454. http://dx.doi.org/10.1095/biolreprod.106.055376.
69. Renaud, S.J., R. Sullivan, and C.H. Graham. 2009. Tumour necrosis factor alpha stimulates the production of monocyte chemoattractants by extravillous trophoblast cells via differential activation of MAPK pathways. Placenta. 30:313-319. http://dx.doi.org/10.1016/j.placenta.2009.01.001.
70. Renaud, S.J., T. Cotechini, J.S. Quirt, S.K. Macdonald-Goodfellow, M. Othman, and C.H. Graham. 2011. Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J. Immunol. 186:1799-1808. http://dx.doi.org/10.4049/jimmunol.1002679.
71. Rittirsch, D., M.A. Flierl, D.E. Day, B.A. Nadeau, S.R. McGuire, L.M. Hoesel, K. Ipaktchi, F.S. Zetoune, J.V. Sarma, L. Leng, et al. 2008. Acute lung injury induced by lipopolysaccharide is independent of complement activation. J. Immunol. 180:7664-7672.
72. Roberts, J.M., and H.S. Gammill. 2005. Preeclampsia: recent insights. Hypertension. 46:1243-1249. http://dx.doi.org/10.1161/01.HYP.0000188408. 49896.c5.
73. Roberts, V.H., J. Smith, S.A. McLea, A.B. Heizer, J.L. Richardson, and L. Myatt. 2009. Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta. 30:169-175. http://dx.doi.org/10.1016/j.placenta.2008.11.019.
74. Roggensack, A.M., Y. Zhang, and S.T. Davidge. 1999. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 33:83-89. http://dx.doi.org/10.1161/01.HYP.33.1.83.
75. Rubin, L.H., K. Witkiewitz, J.S. Andre, and S. Reilly. 2007. Methods for handling missing data in the behavioral neurosciences: don't throw the baby rat out with the bath water. JUNE. 5:A71-A77.
76. Rustveld, L.O., S.F. Kelsey, and R. Sharma. 2008. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern. Child Health J. 12:223-242. http://dx.doi.org/10 .1007/s10995-007-0224-1.
77. Salminen, A., R. Paananen, R. Vuolteenaho, J. Metsola, M. Ojaniemi, H. Autio-Harmainen, and M. Hallman. 2008. Maternal endotoxin-induced preterm birth in mice: fetal responses in toll-like receptors, collectins, and cytokines. Pediatr. Res. 63:280-286. http://dx.doi.org/10.1203/PDR .0b013e318163a8b2.
78. Shynlova, O., T. Nedd-Roderique, Y. Li, A. Dorogin, and S.J. Lye. 2013. Myometrial immune cells contribute to term parturition, preterm labour and post-partum involution in mice. J. Cell. Mol. Med. 17:90-102. http://dx.doi.org/10.1111/j.1582-4934.2012.01650.x.
79. Smith, G.N., M.C. Walker, and M.J. McGrath. 1999. Randomised, doubleblind, placebo controlled pilot study assessing nitroglycerin as a tocolytic. Br. J. Obstet. Gynaecol. 106:736-739. http://dx.doi.org/10.1111/j.1471-0528.1999.tb08376.x.
80. Soares, M.J., D. Chakraborty, M.A. Karim Rumi, T. Konno, and S.J. Renaud. 2012. Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface. Placenta. 33:233-243. http://dx.doi.org/10.1016/j.placenta.2011.11.026.
81. Strevens, H., D. Wide-Swensson, A. Grubb, A. Hansen, T. Horn, I. Ingemarsson, S. Larsen, J.R. Nyengaard, O. Torffvit, J. Willner, and S. Olsen. 2003. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG. 110:825-830. http://dx.doi.org/10.1111/j.1471-0528.2003.02051.x.
82. Szarka, A., J. Rigó Jr., L. Lázár, G. Beko, and A. Molvarec. 2010. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 11:59. http://dx.doi.org/10.1186/1471-2172-11-59.
83. Todt, J.C., Y. Yang, J. Lei, M.R. Lauria, Y. Sorokin, D.B. Cotton, and F.D. Yelian. 1996. Effects of tumor necrosis factor-alpha on human trophoblast cell adhesion and motility. Am. J. Reprod. Immunol. 36:65-71. http://dx.doi.org/10.1111/j.1600-0897.1996.tb00141.x.
84. Tosun, M., H. Celik, B. Avci, E. Yavuz, T. Alper, and E. Malatyalioglu. 2010. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia. J. Matern. Fetal Neonatal Med. 23:880-886. http://dx.doi.org/10.3109/14767051003774942.
85. Valensise, H., B. Vasapollo, G. Gagliardi, and G.P. Novelli. 2008. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 52:873-880. http://dx.doi .org/10.1161/HYPERTENSIONAHA.108.117358.
86. van Asselt, K., S. Gudmundsson, P. Lindqvist, and K. Marsal. 1998. Uterine and umbilical artery velocimetry in pre-eclampsia. Acta Obstet. Gynecol. Scand. 77:614-619. http://dx.doi.org/10.1034/j.1600-0412.1998.770607.x.
87. Vatten, L.J., and R. Skjaerven. 2004. Is pre-eclampsia more than one disease? BJOG. 111:298-302. http://dx.doi.org/10.1111/j.1471-0528 .2004.00071.x.
88. Venegas-Pont, M., M.B. Manigrasso, S.C. Grifoni, B.B. LaMarca, C. Maric, L.C. Racusen, P.H. Glover, A.V. Jones, H.A. Drummond, and M.J. Ryan. 2010. Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus. Hypertension. 56:643-649. http://dx.doi.org/10 .1161/HYPERTENSIONAHA.110.157685.
89. Vercruysse, L., S. Caluwaerts, C. Luyten, and R. Pijnenborg. 2006. Interstitial trophoblast invasion in the decidua and mesometrial triangle during the last third of pregnancy in the rat. Placenta. 27:22-33. http://dx.doi.org/10.1016/j.placenta.2004.11.004.
90. Viktil, K.K., A. Engeland, and K. Furu. 2012. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand. J. Rheumatol. 41:196-201. http://dx.doi.org/10.3109/03009742.2011.626442.
91. Yung, H.W., S. Calabrese, D. Hynx, B.A. Hemmings, I. Cetin, D.S. Charnock-Jones, and G.J. Burton. 2008. Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am. J. Pathol. 173:451-462. http://dx.doi.org/10.2353/ajpath.2008.071193.
92. Zhang, H., Y. Park, J. Wu, Xp. Chen, S. Lee, J. Yang, K.C. Dellsperger, and C. Zhang. 2009. Role of TNF-alpha in vascular dysfunction. Clin. Sci. 116:219-230. http://dx.doi.org/10.1042/CS20080196.
93. Zhou, P., X. Luo, H.B. Qi, W.J. Zong, H. Zhang, D.D. Liu, and Q.S. Li. 2012. The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum. Inflamm. Res. 61:1005-1012. http://dx.doi.org/10.1007/s00011-012-0507-x.